ASH 43rd (2001)

Drupal spam blocked by CleanTalk.
Title Content type
Allogeneic Blood Stem Cell Transplantation after Dose Reduced Conditioning without ATG in Patients with Severe Aplastic Anemia. (click for details)
Fludarabine with Cyclophosphamide and Mitoxantrone (FCM) in Resistant or Relapsed Chronic Lymphocytic Leukemia (CLL): Final Results of a Phase II Study. (click for details)
Refractory aspergillus Pneumonia in Patients with Acute Leukemia: Successful Therapy with Combination Caspofungin and Liposomal Amphotericin. (click for details)
Sequential Positive PCR Assays Are Highly Predictive of Invasive Fungal Infections in Immunocompromised Hematology Patients. (click for details)
Campath-1H in Refractory B-CLL - Complete Remission Despite p53 Gene Mutation. (click for details)
Early High Resolution Computed Tomography (HRCT) Scans Allow for Prompt Diagnosis and More Efficacious Treatment of Invasive Pulmonary aspergillosis (IPA) in Immunocompromised Patients with Haematologic Malignancies. (click for details)
Chronic Renal Failure: An Underestimated Complication of Allogeneic Bone Marrow Transplantation. (click for details)
Assessment of Maximum Tolerated Dose (MTD) and Pharmacokinetics (PK) of FK463 in Neutropenic Patients after Haematopoetic Stem Cell Transplantation. (click for details)
A Phase I/II Study of Induction Chemotherapy with Daunorubicin, Cytarabine, Topotecan, and Etoposide (DATE) for De Novo, Relapsed or Refractory AML, or AML Arising from a Previous Phase of MDS in Treatment of Patients Ages 16-75. (click for details)
A Multicenter Randomized Trial by Italian Lymphoma Intergroup (ILI) Comparing High Dose Chemotherapy (HDS) with Autologous Stem Cell Transplantation (ASCT) vs Intensified Chemotherapy MegaCEOP in High Risk Diffuse Large Cell Lymphoma (DLCL): No Differenc (click for details)


Subscribe to ASH 43rd (2001)